Definitive Forum on the Realities of Biosimilars

What:

^[1]The only event where the industry leaders driving the business of biosimilars come together to set the standards shaping the rapidly evolving legal and regulatory landscape.

Whether you are on the branded or generic side, you cannot afford to miss this opportunity because you will:

• Hear directly from the FDA on how they will implement the abbreviated pathway
• Benchmark your strategy against market leaders such as Amgen, Dr. Reddy’s,
• Eli Lilly, Merck, Momenta, Pfizer, Sandoz and many more
• Gain priceless knowledge from the actual scientists, economists, in-house
• and outside counsel thought leaders blazing the FDA’s biosimilar pathway
• Network with peers facing the same regulatory, research and development cost, and patent management challenges in an true knowledge sharing environment

With an estimated $150 billion in potential biologics revenue at stake annually and a wave of patent expirations starting in 2014, there will be a hard-fought battle to protect and increase market share.

When:

Tuesday, May 22 to Wednesday, May 23, 2012

Where:

New York Marriott
East Side
New York, NY

How:

Register for ACI’s Biosimilars Conference  by calling 888-224-2480, faxing your form to 877-927-1563, or registering online at www.AmericanConference.com/Biosimilars ^[2].

PatentBaristas.com is a Media Sponsor of this event.  Readers of Patent Baristas are entitled to $200 off the current conference price tier.   The discount code you will need for this is: PB 200.